In this issue:
Long-term macrolides and respiratory microbiota in non-CF bronchiectasis
The multidimensional FACED score for non-CF bronchiectasis
Inhaled aztreonam for non-CF bronchiectasis
Atorvastatin as a stable bronchiectasis treatment
Domiciliary IV antibiotics for bronchiectasis
M. avium infection in non-CF bronchiectasis
Clinical course and prognostic factors for pulmonary aspergilloma
Factors associated with FEV1 decline in CF
Lung clearance index predicts pulmonary exacerbations in young CF patients
Lumacaftor plus ivacaftor for D508 mutated CF
Please login below to download this issue (PDF)